SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Brody who wrote (858)5/23/1999 12:00:00 PM
From: Angelo  Read Replies (1) of 2344
 
Michael, I think Biomira is one of the best investment you can make.
All you can loose is $4000 U.S. but if they will get the approval
(which I strongly believe they will)your $4000 U.S. dollars will
become $100.000 in the next three years after the aproval.Some people
on this thread might say I'm dreaming, that is not true.I will
back up my words,take a look at Biochem Pharmaceutical,find out
how many time they split after receiving approval on their a.i.d.s.
drug, which by the way it was not a cancer vaccine.If Biochem pharma
wouldn't split their share price I believe would be over $200 Canadian.A cancer vaccine if approved is a block buster drug. Naturally this is my opinion, (if you go in my personal profile
you will find Biomira mentioned quite often)other people opinion
might be different.Regarding F.D.A. approval for phase III testing,
that approval, I believe has already been received,but it is possible
that biomira might receive an early approval depending on the outcome
of their testing in about six months.There is going to an investor
teleconference,and in that occasion the stock price might go and will
probally go up depending of what they have to say.
Angelo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext